DE60137969D1 - Ein chimäres protein das nichttoxische pseudomonas exotoxin a und typ iv pilin sequenzen enthält - Google Patents
Ein chimäres protein das nichttoxische pseudomonas exotoxin a und typ iv pilin sequenzen enthältInfo
- Publication number
- DE60137969D1 DE60137969D1 DE60137969T DE60137969T DE60137969D1 DE 60137969 D1 DE60137969 D1 DE 60137969D1 DE 60137969 T DE60137969 T DE 60137969T DE 60137969 T DE60137969 T DE 60137969T DE 60137969 D1 DE60137969 D1 DE 60137969D1
- Authority
- DE
- Germany
- Prior art keywords
- type
- pseudomonas exotoxin
- chimeric protein
- protein containing
- containing nontoxic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 102000037865 fusion proteins Human genes 0.000 title abstract 5
- 108020001507 fusion proteins Proteins 0.000 title abstract 5
- 108700033844 Pseudomonas aeruginosa toxA Proteins 0.000 title abstract 3
- 231100000252 nontoxic Toxicity 0.000 title abstract 3
- 230000003000 nontoxic effect Effects 0.000 title abstract 3
- 102000040430 polynucleotide Human genes 0.000 abstract 3
- 108091033319 polynucleotide Proteins 0.000 abstract 3
- 239000002157 polynucleotide Substances 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 2
- 108010000916 Fimbriae Proteins Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Heart & Thoracic Surgery (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Ophthalmology & Optometry (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25787700P | 2000-12-21 | 2000-12-21 | |
PCT/US2001/049143 WO2002060935A2 (en) | 2000-12-21 | 2001-12-20 | A chimeric protein comprising non-toxic pseudomonas exotoxin a and type iv pilin sequences |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60137969D1 true DE60137969D1 (de) | 2009-04-23 |
Family
ID=22978159
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60137969T Expired - Lifetime DE60137969D1 (de) | 2000-12-21 | 2001-12-20 | Ein chimäres protein das nichttoxische pseudomonas exotoxin a und typ iv pilin sequenzen enthält |
Country Status (9)
Country | Link |
---|---|
US (2) | US7314625B2 (de) |
EP (1) | EP1379550B1 (de) |
JP (2) | JP2004528018A (de) |
AT (1) | ATE425180T1 (de) |
CA (1) | CA2432731A1 (de) |
DE (1) | DE60137969D1 (de) |
DK (1) | DK1379550T3 (de) |
ES (1) | ES2322240T3 (de) |
WO (1) | WO2002060935A2 (de) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK1000163T3 (da) * | 1997-07-11 | 2006-02-06 | Us Gov Health & Human Serv | Pseudomonas-exotoksin A-lignende kimære immunogener |
WO2001030392A2 (en) | 1999-10-22 | 2001-05-03 | The Government Of The United States Of America, Represented By The Secretary Of The Department Of Health And Human Services | Delivery of proteins across polar epithelial cell layers |
GB0212666D0 (en) | 2002-05-31 | 2002-07-10 | Secr Defence | Immunogenic sequences |
CA2583226A1 (en) * | 2004-10-04 | 2006-04-20 | Trinity Biosystems, Inc. | Methods and compositions for immunizing against pseudomonas infection |
US20090155297A1 (en) * | 2004-10-04 | 2009-06-18 | Trinity Biosystems, Inc. | Methods and Compositions for Inducing an Immune Response Against Multiple Antigens |
US7713737B2 (en) * | 2004-10-04 | 2010-05-11 | Trinity Biosystems, Inc. | Methods and compositions for needleless delivery of macromolecules |
AU2006247188A1 (en) | 2005-05-18 | 2006-11-23 | Children's Hospital & Research Center At Oakland | Methods and compositions for immunizing against chlamydia infection |
EP1919494A4 (de) * | 2005-07-22 | 2011-11-09 | Univ Colorado Regents | Nichttoxischer biofolien-hemmer |
US7666991B2 (en) * | 2005-12-05 | 2010-02-23 | Trinity Biosystems, Inc. | Compositions for needleless delivery of antibodies |
US20090148401A1 (en) * | 2005-12-05 | 2009-06-11 | Trinity Biosystems, Inc. | Methods and compositions for needleless delivery of binding partners |
EP2010205A2 (de) * | 2006-03-16 | 2009-01-07 | Trinity Biosystems, Inc. | Verfahren zur erhöhung der grösse von tieren mit nadellos abgegebenen konstrukten |
EP2040744B1 (de) | 2006-07-25 | 2016-03-09 | The Secretary of State for Defence | Francisella lebendvakzine |
US20090092660A1 (en) * | 2006-08-09 | 2009-04-09 | Trinity Biosystems, Inc. | Methods and compositions for needleless delivery of particles |
US20100189776A1 (en) | 2007-03-16 | 2010-07-29 | Cancer Research Technology Ltd | Anti-androgen peptides and uses thereof in cancer therapy |
GB0906234D0 (en) | 2009-04-14 | 2009-05-20 | Secr Defence | Vaccine |
CA2768598A1 (en) * | 2009-07-22 | 2011-01-27 | Cenix Bioscience Gmbh | Delivery system and conjugates for compound delivery via naturally occurring intracellular transport routes |
US8961984B2 (en) * | 2009-10-08 | 2015-02-24 | Arch Biophysics, Inc. | Surface-coated structures and methods |
US11246915B2 (en) | 2010-09-15 | 2022-02-15 | Applied Molecular Transport Inc. | Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo |
EP2667898A1 (de) * | 2011-01-26 | 2013-12-04 | Cenix Bioscience GmbH | Freisetzungssystem und konjugate zur freisetzung einer verbindung über natürlich auftretende intrazelluläre transportwege |
EP3762009B1 (de) | 2018-03-08 | 2022-05-11 | Applied Molecular Transport Inc. | Von toxinen abgeleitete konstrukte zur oralen verabreichung |
CA3119179A1 (en) | 2018-11-07 | 2020-05-14 | Applied Molecular Transport Inc. | Cholix-derived carriers for oral delivery of heterologous payload |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4735800A (en) * | 1983-09-09 | 1988-04-05 | Molecular Genetics, Inc. | Vaccines against rift valley fever virus |
US6022950A (en) | 1984-06-07 | 2000-02-08 | Seragen, Inc. | Hybrid molecules having translocation region and cell-binding region |
US5668255A (en) | 1984-06-07 | 1997-09-16 | Seragen, Inc. | Hybrid molecules having translocation region and cell-binding region |
US5082927A (en) | 1986-09-24 | 1992-01-21 | The United States Of America As Represented By The Department Of Health And Human Services | Selectively cytotoxic IL-4-PE40 fusion protein |
US6051405A (en) | 1986-09-24 | 2000-04-18 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Constructs encoding recombinant antibody-toxin fusion proteins |
US4892827A (en) | 1986-09-24 | 1990-01-09 | The United States Of America As Represented By The Department Of Health And Human Services | Recombinant pseudomonas exotoxins: construction of an active immunotoxin with low side effects |
CA1340530C (en) * | 1989-04-28 | 1999-05-04 | Kok Kheong Lee | Synthetic pseudomonas aeruginosa pilin peptide and related vaccines and diagnostics |
JPH05502880A (ja) | 1989-12-22 | 1993-05-20 | セラジェン・インコーポレーテッド | トランスロケーション領域および細胞結合領域を有するハイブリッド分子 |
US5458878A (en) | 1990-01-02 | 1995-10-17 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | P. exotoxin fusio proteins have COOHG220101al alterations which increase cytotoxicity |
DE69131449T2 (de) * | 1990-05-11 | 1999-11-25 | The United States Of America, Represented By The Secretary | Verbesserte exotoxine aus pseudomonas mit geringer toxität bei tieren und hoher zelltötender aktivität |
US5328984A (en) | 1991-03-04 | 1994-07-12 | The United States As Represented By The Department Of Health & Human Services | Recombinant chimeric proteins deliverable across cellular membranes into cytosol of target cells |
WO1993011791A1 (en) * | 1991-12-18 | 1993-06-24 | The State Of Oregon Acting By And Through The Oregon State Board Of Higher Education On Behalf Of Oregon State University | Antigenic preparations that stimulate production of antibodies which bind to the pili of type iv piliated bacteria |
CA2136724A1 (en) | 1992-06-18 | 1993-12-23 | Ira H. Pastan | Recombinant pseudomonas exotoxin with increased activity |
US5635599A (en) | 1994-04-08 | 1997-06-03 | The United States Of America As Represented By The Department Of Health And Human Services | Fusion proteins comprising circularly permuted ligands |
DE69522216T2 (de) | 1994-05-13 | 2002-05-02 | Biovation Ltd | Zielzellen-bindende chimäre Peptide |
US5573916A (en) | 1994-05-19 | 1996-11-12 | Coretech, Inc. | Immunogenic constructs comprising b-cell and t-cell epitopes on common carrier |
AU695196B2 (en) | 1994-11-01 | 1998-08-06 | Winfried Wels | Nucleic acid transfer system |
WO1997013529A1 (en) | 1995-10-13 | 1997-04-17 | The Government Of The United States Of America, Represented By The Secretary Of The Department Of Health And Human Services | Immunotoxin containing a disulfide-stabilized antibody fragment |
EP0941334B1 (de) | 1996-11-06 | 2004-06-02 | THE UNITED STATES OF AMERICA, as represented by the Secretary of the Department of Health and Human Services | Protease-aktivierbare pseudomonas exotoxin-a-ähnliche proproteine |
AU6769998A (en) | 1997-03-26 | 1998-10-20 | Board Of Regents, The University Of Texas System | Methods and compositions for using membrane-penetrating proteins to carry materials across cell membranes |
US20030054012A1 (en) * | 2000-05-12 | 2003-03-20 | Fitzgerald David J. | Pseudomonas exotoxin a-like chimeric immunogens for eliciting a secretory iga-mediated immune response |
US7314632B1 (en) * | 1997-07-11 | 2008-01-01 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Pseudomonas exotoxin A-like chimeric immunogens |
ATE340863T1 (de) | 1997-07-11 | 2006-10-15 | Us Gov Health & Human Serv | Pseudomonas exotoxin a-ähnliche chimerische immunogene zum auslösen einer sekretorischen iga- vermittelten immunantwort |
EP1082342A2 (de) * | 1998-05-06 | 2001-03-14 | The Governors Of The University Of Alberta | Pseudomonas aeruginosa impfstoff |
-
2001
- 2001-12-20 EP EP01997090A patent/EP1379550B1/de not_active Expired - Lifetime
- 2001-12-20 WO PCT/US2001/049143 patent/WO2002060935A2/en active Application Filing
- 2001-12-20 CA CA002432731A patent/CA2432731A1/en not_active Abandoned
- 2001-12-20 DK DK01997090T patent/DK1379550T3/da active
- 2001-12-20 DE DE60137969T patent/DE60137969D1/de not_active Expired - Lifetime
- 2001-12-20 AT AT01997090T patent/ATE425180T1/de not_active IP Right Cessation
- 2001-12-20 JP JP2002561503A patent/JP2004528018A/ja active Pending
- 2001-12-20 US US10/432,412 patent/US7314625B2/en not_active Expired - Fee Related
- 2001-12-20 ES ES01997090T patent/ES2322240T3/es not_active Expired - Lifetime
-
2006
- 2006-05-15 US US11/434,934 patent/US20070003578A1/en not_active Abandoned
-
2008
- 2008-06-04 JP JP2008147377A patent/JP2008237227A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP1379550B1 (de) | 2009-03-11 |
JP2008237227A (ja) | 2008-10-09 |
ATE425180T1 (de) | 2009-03-15 |
WO2002060935A8 (en) | 2004-01-15 |
DK1379550T3 (da) | 2009-07-06 |
ES2322240T3 (es) | 2009-06-18 |
JP2004528018A (ja) | 2004-09-16 |
US20070003578A1 (en) | 2007-01-04 |
WO2002060935A3 (en) | 2003-11-20 |
WO2002060935A2 (en) | 2002-08-08 |
US20040071731A1 (en) | 2004-04-15 |
US7314625B2 (en) | 2008-01-01 |
EP1379550A2 (de) | 2004-01-14 |
CA2432731A1 (en) | 2002-08-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60137969D1 (de) | Ein chimäres protein das nichttoxische pseudomonas exotoxin a und typ iv pilin sequenzen enthält | |
ATE466952T1 (de) | Poly-zinkfinger-proteine mit verbesserten linkern | |
AU9063801A (en) | Methods and compositions for diseases associated with amyloidosis | |
DE60129202D1 (de) | Caspasen-aktivatoren | |
BR0112969A (pt) | Método de utilização de dicetopiperazinas e composições contendo-as | |
ATE457780T1 (de) | Ein dikationischer diazofarbstoff enthaltende farbstoffzusammensetzung zum färben von keratinischen fasern | |
MXPA03011393A (es) | Composicion para tenido de fibras queratinicas que comprende colorante diazoico dicationico particular. | |
MXPA02011656A (es) | Moleculas de acido nucleico nrg-2, polipeptidos, y metodos de diagnostico y terapeuticos. | |
HRP20010036B1 (en) | Neurotrophic growth factor | |
DK1123414T3 (da) | Antisense-modulering af integrin alpha 4.ekspression | |
HK1154623A1 (en) | Isolated luciferases and the use thereof | |
WO1999000407A3 (en) | Improved bacillus thuringiensis toxin | |
DK1037916T3 (da) | Erythrovirus og dets anvendelser | |
DE60139959D1 (de) | Nukleinsäureadjuvantien | |
DK1127064T3 (da) | Hidtil ukendte aminosyresekvenser, DNA, der koder for aminosyresekvenserme, antistoffer, der er rettet mod sådanne sekvenser, og forskellige anvendelser deraf | |
EP1279677A4 (de) | Gd3 mimetische peptide(05.11.01) | |
ATE385805T1 (de) | Neue peptide | |
EA199900893A1 (ru) | Бактериальные плазмиды | |
PE20399A1 (es) | Muteina ob | |
TR200003608T2 (tr) | Moraxella Catarrhalis'e ait BASB027 proteinleri ve genleri. | |
WO2002024864A3 (en) | Antisense modulation of syntaxin 4 interacting protein expression | |
NO20014720L (no) | In vivo fargeforbindelser og fremgangsmåter for anvendelse for identifisering av dysplastisk vev | |
KR970700770A (ko) | Htra-프로모터를 사용하여 독성이 약화된 박테리아내에서 이종 단백질을 발현시키는 방법(expression of heterologous proteins in attenuated bacteria using the htra-promoters) | |
DK1056872T3 (da) | DNA-sekvenser indeholdende en overförselsmekanisme ved konjugering | |
IT1318483B1 (it) | Dispositivo per la chiusura di un capo di abbigliamento o simile, adelevata praticita' di impiego. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |